Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds for Medium Supplement

Items 1-10 of 16

Page
per page
  1. DAPT (GSI-IX)
    A8200 DAPT (GSI-IX)
     20 Citation
    Summary: γ-secretase inhibitor
      ≥21.62 mg/mL
  2. GDC-0068 (RG7440)
    A3006 GDC-0068 (RG7440)
     2 Citation
    Target: Akt
    Summary: Pan-AKT inhibitor,highly selective
      ≥22.9 mg/mL
  3. Y-27632 dihydrochloride
    A3008 Y-27632 dihydrochloride
     70 Citation
    Target: ROCK
    Summary: ROCK inhibitor
      ≥111.2 mg/mL
  4. MK-2206 dihydrochloride
    A3010 MK-2206 dihydrochloride
     52 Citation
    Target: Akt
    Summary: Akt1/2/3 inhibitor
      insoluble in EtOH; ≥12.01 mg/mL
  5. CHIR-99021 (CT99021)
    A3011 CHIR-99021 (CT99021)
     28 Citation
    Target: GSK-3
    Summary: GSK-3 inhibitor
      ≥23.27 mg/mL
  6. A 83-01
    A3133 A 83-01
     11 Citation
    Summary: ALK inhibitor
      ≥21.1 mg/mL
  7. SB 431542
    A8249 SB 431542
     28 Citation
    Summary: ALK5 inhibitor
  8. SB202190 (FHPI)
    A1632 SB202190 (FHPI)
     20 Citation
    Target: p38
    Summary: MAPK inhibitor
  9. Acetylcysteine
    A8356 Acetylcysteine
    Summary: Antioxidant;mucolytic agent
      ≥44.6 mg/mL
  10. Tretinoin (Aberela)
    A8539 Tretinoin (Aberela)
    Target: RAR/RXR
    Summary: retinoic acid, treats acne vulgaris and keratosis pilaris
      insoluble in H2O; ≥11.9 mg/mL

Items 1-10 of 16

Page
per page